@fdna

Detecting rare disease early with the help of AI

 United States
FDNA.com
Joined March 2014
  • Tweets1.3K
  • Following1.1K
  • Followers5.9K
Announcing today that @fdna has been selected by @ARPA_H as a performer in the Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program. ARPA-H awarded FDNA a contract as part of a larger investment in RAPID.
Page 1 of FDNA's press release. Headline: FDNA Selected by ARPA-H to Help Families Reach a Rare Disease Diagnosis Sooner. Dated Atlanta, August 31, 2026. FDNA has been selected as a performer in ARPA-H's Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program. The release describes how Family Health Checker gives parents a digital front door to bring concerns, photos, symptoms and health history into a clinical workflow, and how Face2Gene helps clinicians develop a differential list of possible syndromic conditions, with diagnosis remaining a clinical determination. It closes with a quote from CEO and Co-Founder Erik A. Feingold: Families shouldn't need to understand the rare disease system before the system can help them.

ALT Page 1 of FDNA's press release. Headline: FDNA Selected by ARPA-H to Help Families Reach a Rare Disease Diagnosis Sooner. Dated Atlanta, August 31, 2026. FDNA has been selected as a performer in ARPA-H's Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program. The release describes how Family Health Checker gives parents a digital front door to bring concerns, photos, symptoms and health history into a clinical workflow, and how Face2Gene helps clinicians develop a differential list of possible syndromic conditions, with diagnosis remaining a clinical determination. It closes with a quote from CEO and Co-Founder Erik A. Feingold: Families shouldn't need to understand the rare disease system before the system can help them.

Page 2 of FDNA's press release. Section About ARPA-H RAPID: RAPID is led by program manager Scott Gorman in ARPA-H's Proactive Health Office. More than 10,000 rare diseases affect over 350 million people worldwide, and the diagnostic odyssey takes six years on average. RAPID is a 4.5-year program to build a large rare disease dataset and develop AI tools. Section About FDNA: headquartered in Atlanta, develops computer vision and AI-powered phenotyping and differential decision-support technologies. Face2Gene is used across more than 10,000 clinical sites in over 130 countries. Family Health Checker is non-diagnostic. Includes an ARPA-H funding disclaimer and media contact details for Stefanie Eichner.

ALT Page 2 of FDNA's press release. Section About ARPA-H RAPID: RAPID is led by program manager Scott Gorman in ARPA-H's Proactive Health Office. More than 10,000 rare diseases affect over 350 million people worldwide, and the diagnostic odyssey takes six years on average. RAPID is a 4.5-year program to build a large rare disease dataset and develop AI tools. Section About FDNA: headquartered in Atlanta, develops computer vision and AI-powered phenotyping and differential decision-support technologies. Face2Gene is used across more than 10,000 clinical sites in over 130 countries. Family Health Checker is non-diagnostic. Includes an ARPA-H funding disclaimer and media contact details for Stefanie Eichner.

1
1
2
85
It's #SMAAwarenessMonth. Worried about your child's movement or strength? Family Health Checker helps you organize symptoms & history into a clinician-ready summary for a more productive visit. Educational, not a diagnosis. #RareDisease
264
Today is Plasminogen Deficiency Awareness Day. PLGD-1 is often mistaken for chronic pink eye, recurring ear infections, or a persistent cough. Earlier recognition matters. FDNA stands with the rare disease community. #PLGD #RareDisease
🤖 Made with AI
FDNA graphic for Plasminogen Deficiency Awareness Day noting that PLGD-1 is often mistaken for chronic pink eye, recurring ear infections, or a persistent cough, and that earlier recognition matters.

ALT FDNA graphic for Plasminogen Deficiency Awareness Day noting that PLGD-1 is often mistaken for chronic pink eye, recurring ear infections, or a persistent cough, and that earlier recognition matters.

1
1
27
Today is #RareDiseaseDay 💜 We stand with millions of families navigating rare conditions, long diagnostic journeys, and unanswered questions. Raising awareness and accelerating answers makes a difference — today and every day. #RareDiseaseDay
1
39
Proud to participate in #RareDiseaseDay Cleveland 2026 at @cwru. FDNA CEO & Co-Founder Erik A. Feingold joined a fireside chat on AI as a catalyst for diagnosis and equity in pediatric & rare disease care. Advancing earlier diagnosis through clinical decision support.
1
49
A long journey led Annette to her son’s diagnosis: KBG syndrome. Now, through the @KBGFdn, she's helping other families get answers sooner. We're proud to partner with the Foundation to support earlier recognition of KBG. #RareDisease #Face2Gene #KBGFoundation #Genetics
1
2
1
4
169
In the world of rare genetic diseases, early diagnosis is often the key to better patient outcomes. Dr. Bruno Bordest has been working to bridge this gap by introducing #Face2Gene to pediatricians and general practitioners: fdna.com/blog/the-importance…
58
Every rare disease journey begins with a question and a search for answers. At FDNA, we harness the power of AI to bring those answers closer. Find out more: fdna.com
1
1
508
A key aspect of the study was the distinctive facial features shared by affected children. Sarah Savage presents how Face2Gene's GestaltMatcher technology was used to objectively assess these features at #ACMG2025. #Genetics
81
Erin Wadman is discussing the identification of Fetal Fentanyl Syndrome at #ACMG2025. Shared prenatal history of opioid use disorder with known fentanyl use throughout pregnancy emerged as a potential cause of this novel condition. #Face2Gene #Genetics
1
73
Dr. Karen Gripp is moderating the session 'Fetal Fentanyl Syndrome — A Teratogen-Induced Embryopathy Masquerading as a Metabolic Disease' at #ACMG2025. Important discussions on this emerging condition! #Face2Gene #Genetics
1
104
Load more